scorecard

You Searched For "AstraZeneca diabetic drug" and got 18 results


Sort By:


Business Insider Latest Story Image
1 min read

AstraZeneca India gets approval to market anti-diabetes drug

Drug firm AstraZeneca India on Tuesday said it has received approval from the country's drug regula…

PTI   


Business Insider Latest Story Image
2 mins read

Covid-19 pushes up sales of cardiac and anti-diabetic drugs

The changes in the medication needs of the masses due to the novel Coronavirus pandemic seems …

Dr. Catherine Schuster-Bruce   


Business Insider Latest Story Image
7 mins read

These are the top-selling anti-diabetes drugs in India

Pharmaceutical giants across the world have witnessed higher sales in drugs related to respirat…

Business Insider Latest Story Image
1 min read

After Britain, AstraZeneca might launch innovative drugs in India

The Brit company is reposing its faith in the new drug pipeline so that it can grow in India, even …

Business Insider Latest Story Image
7 mins read

How much protection you get from one shot of the Pfizer, AstraZeneca, and Moderna vaccines, according to the best available data

One dose of Pfizer or Moderna vaccines appears at least 80% effective against symptomatic COVID-19.…

Dr. Catherine Schuster-Bruce   


Business Insider Latest Story Image
4 mins read

France admits it needs to repair the image of AstraZeneca's COVID-19 vaccine after struggling to convince people to take it

The admission came amid a wider trend of Europeans hesitating over the jab. Regulators say it is sa…

Marianne Guenot   


Business Insider Latest Story Image
1 min read

Glenmark gets tentative nod from USFDA for generic type-2 diabetes tablets

Citing IQVIA sales data for the 12 month period ending January 2020, the company said Farxiga tabl…

PTI   


Business Insider Latest Story Image
5 mins read

America's top pharma CEOs are about to get grilled by Congress over the cost of their drugs

The US spent an estimated $344.5 billion on prescription drugs in 2018, and the figure is expected …

Emma Court   


Business Insider Latest Story Image
1 min read

In One Paragraph, Here's Why A Pfizer Wants To Buy AstraZeneca

Strategic rationale. Astra Zeneca would dramatically boost Pfizer's presence in primary care (incl.…

Sam Ro   


Business Insider Latest Story Image
3 mins read

These Are The Drugs Doctors Get Paid The Most To Promote

It's super vague, which is part of the reason advocacy organizations have been pushing drug makers …

Erin Brodwin   


Business Insider Latest Story Image
3 mins read

India's G20 presidency will reflect interests of global south, says Jaishankar

Jaishankar made these remarks during the annual flagship event co-hosted by the Ministry of Externa…

ANI   


Business Insider Latest Story Image
4 mins read

We got a look at the pitch deck of buzzy Silicon Valley health-tech startup Sempre Health. It reveals how a $4 billion industry is ripe for disruption.

There are rivals, including drug discount companies like GoodRx and Blink Health, and industry gian…

Emma Court   


Business Insider Latest Story Image
6 mins read

7 top executives told us why big pharma is embracing Amazon's foray into healthcare

The fear is that Amazon will upend the healthcare industry, relentlessly compressing health compani…

Lydia Ramsey   


Business Insider Latest Story Image
3 mins read

Allergan just struck another billion-dollar deal

But using acquisitions of promising drugs as a means to fatten a company's pipeline of products is …

Lydia Ramsey   


Business Insider Latest Story Image
7 mins read

Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050

"The costs to develop a new antibiotic drug are no less expensive compared to development of drugs …

Charlotte Hu   


Business Insider Latest Story Image
3 mins read

10 things you need to know before the opening bell

Nestle blames China for its lowered outlook. Swiss food and drink behemoth Nestle announced sales i…

Jonathan Garber   


Business Insider Latest Story Image
3 mins read

10 things you need to know before the opening bell

Shake Shack crushed estimates. The burger chain reported adjusted earnings of $0.12 per share, topp…

Jonathan Garber